Digital Study Design
ObvioHealth’s experts understand how to design your trial to recruit and train the optimal cohort and root out statistical “noise”—so you get the robust evidence you need.
ObvioHealth’s experts understand how to design your trial to recruit and train the optimal cohort and root out statistical “noise”—so you get the robust evidence you need.
Factors most likely to drive poor results are flawed study design, wrong choice of endpoint, and inadequate sample size*
*See analysis of 640 Phase III trials by Hwang et. al.
Efficient trials minimize participant burden and maximize data accuracy.
ObvioHealth’s in-house team of clinicians, data scientists, and engineers work in tandem with sponsors and CROs to design digital trials that ensure data integrity. Smoother, more efficient participant and site workflows result in more streamlined study conduct.
Merging clinical science with data science to determine the best endpoints and outcomes for a given TA and protocol.
Providing recommendations for instruments that are technically and clinically valid as well as user-friendly.
Multi-vital devices can make life easier for patients. But, the more things get measured, the more the quality of the data tends to suffer. Instrument selection must determine the right balance between these sometimes conflicting criteria.
Reducing the bias, errors, and variability inherent in self-reporting and rater scoring.
ObvioHealth launched one of the first-ever DCT platforms with a mobile app in 2017. Today, we’re a global industry leader delivering DCTs that generate stronger evidence.
The study required a long run-in period to ensure enrollment of participants with the right type of headache. Learn how we designed the study to keep participants engaged prior to active treatment.
.jpg)
